IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?

Y Li; Kazunari Ishii; Hajime Hisaeda; Shinjiro Hamano; M Zhang; Kenji Nakanishi; Takayuki Yoshimoto; Hiroaki Hemmi; Kiyoshi Takeda; Akira Shizuo; Yoichiro Iwakura; Kunisuke Himeno

doi:10.1038/sj.gt.3302240

Related publications

Article2000

Genetically Resistant Mice Lacking IL-18 Gene Develop Th1 Response and Control Cutaneous<i>Leishmania major</i>Infection

Gina M. Monteforte, Kohsuke Takeda, Miriam Rodríguez‐Sosa, Akira Shizuo, John R. David, Abhay R. Satoskar

The Journal of Immunology

Chapter in a book2003

IL-18 and IL-18 Receptor Knockout Mice

Hiroko Tsutsui, Tomohiro Yoshimoto, Haruki Okamura, Akira Shizuo, Kenji Nakanishi

Article2000

Macrophage-derived IL-18 mediated colitis in the murine model of Crohn's disease

Takanori Kanai∥, Mamoru Watanabe, Akira Okazawa, Toshiro Sato, Hiromasa Ishii, Kohsuke Takeda, Akira Shizuo, Masao Ikeda, Masashi Kurimoto, Toshifumi Hibi∥

Gastroenterology

Chapter in a book2001

IL-18

Katherine A. Fitzgerald, Luke O'neill, Andy J.H. Gearing, Robin E. Callard

Article2004

Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ

Masahiro Yamamoto, Soh Yamazaki, Satoshi Uematsu, Shintaro Sato, Hiroaki Hemmi, Katsuaki Hoshino, Tsuneyasu Kaisho, Hirotaka Kuwata, Osamu Takeuchi, Koichiro Takeshige, Takashi Saito, Shoji Yamaoka, Naoki Yamamoto, Shunsuke Yamamoto, Tatsushi Muta, Kiyoshi Takeda, Akira Shizuo

Nature